PRESS RELEASE published on 10/25/2023 at 07:14, 2 years 8 months ago Blue Cap AG publishes key financial figures for the third quarter of 2023 and provides an outlook for further development
PRESS RELEASE published on 09/18/2023 at 20:45, 2 years 9 months ago Blue Cap AG announces successor solution on the board: Dr. Henning von Kottwitz becomes new CEO
PRESS RELEASE published on 09/18/2023 at 20:42, 2 years 9 months ago EQS-Adhoc: Blue Cap AG: Dr. Henning von Kottwitz becomes new CEO
PRESS RELEASE published on 08/25/2023 at 17:21, 2 years 10 months ago Blue Cap AG: Change in the Management Board – Tobias Hoffmann-Becking asks for early termination of his Management Board mandate
PRESS RELEASE published on 08/25/2023 at 17:16, 2 years 10 months ago EQS-Adhoc: Blue Cap AG: Change in the Management Board – Tobias Hoffmann-Becking asks for early termination of his Management Board mandate
PRESS RELEASE published on 08/22/2023 at 07:14, 2 years 10 months ago Blue Cap AG shows solid development in the first half of the year despite economic challenges
PRESS RELEASE published on 07/26/2023 at 07:07, 2 years 11 months ago Blue Cap AG: Significant margin improvement in the second quarter leads to solid development in the first half of 2023
PRESS RELEASE published on 07/17/2023 at 14:44, 2 years 11 months ago EQS-Adhoc: Blue Cap AG decides to increase capital in kind from authorized capital by means of a scrip dividend for the first time; Acceptance rate of the scrip dividend totalling 70% of the share capital
PRESS RELEASE published on 06/23/2023 at 14:59, 3 years ago Blue Cap AG: Annual General Meeting approves dividend of 0.90 euros per share
PRESS RELEASE published on 06/14/2023 at 18:28, 3 years ago Blue Cap AG: Successful sale of the Uniplast Group above net asset value valuation
Published on 06/26/2026 at 14:05, 55 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 1 hour ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 2 hours ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 2 hours 15 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 01:40, 13 hours 20 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/26/2026 at 14:00, 1 hour ago Hong Kong celebrates surge of global enterprises driving investment and opportunities
Published on 06/26/2026 at 14:00, 1 hour ago Bitcoin Group SE publishes 2025 Annual Report: Strategic realignment ensures future viability in the dynamic crypto market
Published on 06/26/2026 at 13:32, 1 hour 28 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 1 hour 29 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 1 hour 30 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 07:00, 8 hours ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 8 hours ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
